Allergy

Allergies and the skin, an interdisciplinary approach in GA²LEN and EAACI activities
pp. 1373-1376(4)
Authors: Zuberbier, T.; Worm, M.

EAACI/GA²LEN Position paper: Present status of the atopy patch test
pp. 1377-1384(8)
Authors: Turjanmaa, K.; Darsow, U.; Niggemann, B.; Rancé, F.; Vanto, T.; Werfel, T.

Regulatory mechanisms of galectin-9 and eotaxin-3 synthesis in epidermal keratinocytes: possible involvement of galectin-9 in dermal eosinophilia of Th1-polarized skin inflammation
pp. 1385-1391(7)
Authors: Igawa, K.; Satoh, T.; Hirashima, M.; Yokozeki, H.

Vascular pattern of the palms - a clinical feature of atopic skin diathesis
pp. 1392-1396(5)
Authors: Schuster, C.; Smolle, J.; Aberer, W.; Kränke, B.

Atopic eczema in children: another harmful sequel of divorce
pp. 1397-1402(6)
Authors: Bockelbrink, A.; Heinrich, J.; Schäfer, I.; Zutavern, A.; Borte, M.; Herbarth, O.; Schaaf, B.; von Berg, A.; Schäfer, T.

Effect of climatic change in children with atopic eczema
pp. 1403-1410(8)
Authors: Byremo, G.; Rød, G.; Carlsen, K. H.

A high-positive patch test load correlates with further positive patch test reactions irrespective of their location
pp. 1411-1415(5)
Authors: Brasch, J.; Geier, J.; Schnuch, A.; Uter, W.

Circulating levels of brain-derived neurotrophic factor correlate with disease severity in the intrinsic type of atopic dermatitis
pp. 1416-1418(3)
Authors: Raap, U.; Werfel, T.; Goltz, C.; Deneka, N.; Langer, K.; Bruder, M.; Kapp, A.; Schmid-Ott, G.; Wedi, B.

Different expression of adhesion molecules and tetraspanins of monocytes of patients with atopic eczema
pp. 1419-1422(4)
Authors: Jockers, J. J.; Novak, N.

Can allergic diseases be prevented prenatally?
pp. 1423-1431(9)
Authors: Boyle, R. J.; Tang, M. L. K.

Hypersensitivity reactions to anticoagulant drugs: diagnosis and management options
pp. 1432-1440(9)
Authors: Bircher, A. J.; Harr, T.; Hohenstein, L.; Tsakiris, D. A.

Serine proteases, their inhibitors and allergy
pp. 1441-1447(7)
Authors: Smith, P. K.; Harper, J. I.

Rising trend of asthma prevalence among Turkish schoolchildren (ISAAC phases I and III)
pp. 1448-1453(6)
Authors: Ones, U.; Akcay, A.; Tamay, Z.; Guler, N.; Zencir, M.

Turkish physicians' perception of allergic rhinitis and its impact on asthma
pp. 1454-1458(5)
Authors: Civelek, E.; Soyer, O. U.; Gemicioglu, B.; Şekerel, B. E.

Hypoallergenic fragment of Par j 2 increases functional expression of Toll-like receptors in atopic children
pp. 1459-1466(8)
Authors: Pace, E.; Duro, G.; Grutta, S. La; Ferraro, M.; Bruno, A.; Bousquet, J.; Bonsignore, G.; Gjomarkaj, M.

Does the pill make a difference? Previous maternal use of contraceptive pills and allergic diseases among offspring
pp. 1467-1472(6)
Authors: Keski-Nisula, L.; Pekkanen, J.; Xu, B.; Putus, T.; Koskela, P.

Release of prostaglandin D₂ and leukotriene C₄ in response to hyperosmolar stimulation of mast cells
pp. 1473-1479(7)
Authors: Gulliksson, M.; Palmberg, L.; Nilsson, G.; Ahlstedt, S.; Kumlin, M.

Eosinophilic esophagitis in adults - no clinical relevance of wheat and rye sensitizations
pp. 1480-1483(4)
Authors: Simon, D.; Straumann, A.; Wenk, A.; Spichtin, H.; Simon, H.-U.; Braathen, L. R.

Urticarial vasculitis with a positive autologous serum skin test: Diagnosis and successful therapy
pp. 1484-1485(2)
Authors: Athanasiadis, G. I.; Pfab, F.; Kollmar, A.; Ring, J.; Ollert, M.

Occupational asthma and allergy to sevoflurane and isoflurane in anaesthetic staff
pp. 1485-1486(2)
Authors: Vellore, A. D.; Drought, V. J.; Sherwood-Jones, D.; Tunnicliffe, B.; Moore, V. C.; Robertson, A. S.; Burge, P. S.

Food allergy as a new risk factor for scurvy
pp. 1487-1488(2)
Authors: Des Roches, A.; Paradis, L.; Paradis, J.; Singer, S.

Obesity and asthma in the Portuguese National Health Survey
pp. 1488-1489(2)
Authors: Moreira, P.; Moreira, A.; Padrão, P.; Delgado, L.

Lower serum concentration of dehydroepiandrosterone sulphate in patients suffering from chronic idiopathic urticaria
pp. 1489-1490(2)
Authors: Kasperska-Zajac, A.; Brzoza, Z.; Rogala, B.

Novel pharmacotherapy of acute hereditary angioedema with bradykinin B₂-receptor antagonist icatibant
pp. 1490-1492(3)
Authors: Bas, M.; Bier, H.; Greve, J.; Kojda, G.; Hoffmann, T. K.

Cutaneous adverse drug reaction induced by a generic substitute of Zyloric^® with a residual sensitization to allopurinol
pp. 1492-1493(2)
Authors: Chandeclerc, M.-L.; Tréchot, P.; Martin, S.; Weber-Muller, F.; Schmutz, J.-L.; Barbaud, A.

Erratum
pp. 1494-1494(1)